The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment—Clinical Points of View and Practical Considerations
Open accessAbstract
HIV infection is responsible for one the most devastating human pandemics. The advent of antiretroviral therapy has changed the course of the pandemic and saved millions of lives. Complex therapeutic regimens have been introduced since 1996 and have contributed to the transformation of HIV infection into a treatable chronic diseases. New types of potent antiretrovirals and their combinations, including "once daily" treatment, have simplified the regimens and diminished side effects. Nevertheless the adherence to antiretroviral therapy remains unsatisfactory and varies between 27 and 80% across different population in various studies, compared with the required level of 95%. The lack of adherence to antiretroviral therapy is a multi-factorial and dynamic process which raises considerable difficulties for long-term follow-up. Current solutions to this problem are complex. These should be applied by a multidisciplinary team and should take into account key features related to both the individual and social factors as well as to the population to whom it belongs (children, teenagers, elderly, marginalized population like drug users, incarcerated patients, sex workers, etc.). Importantly, adherence should continue to be monitored even in patients known to be compliant. In case of subsequent failure the team should identify the reasons for non-adherence and apply the appropriate methods. Where usual methods have no chance of success, a coordinated package of services also known as "harm reduction" can be offered in order to reduce the risks of transmission. The current article analyses the concept of adherence to antiretroviral therapy, the shortcomings of this medication and the methods that can be applied in practice to increase adherence. Emphasis is placed on the analysis of groups at high risk for HIV infection that currently represent the spearhead with which the HIV pandemic is spreading.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BERKMAN, L. F., & SYME, S. L. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112674 · Cited by 5,341
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00004 · Cited by 3,289
Horne, R., & Weinman, J. (1999) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(99)00057-4 · Cited by 2,201
A new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,193
Social and emotional support and its implication for health
Reblin, M., & Uchino, B. N. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f3ad89 · Cited by 901
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America: A Meta-analysis
Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., Rachlis, B., Wu, P., Cooper, C., Thabane, L., et al. (2006) · JAMA · doi:10.1001/jama.296.6.679 · Cited by 899
Self-report measures of medication adherence behavior: recommendations on optimal use
Stirratt, M. J., Dunbar-Jacob, J., Crane, H. M., Simoni, J. M., Czajkowski, S., Hilliard, M. E., Aikens, J. E., Hunter, C. M., Velligan, D. I., Huntley, K., et al. (2015) · Translational Behavioral Medicine · doi:10.1007/s13142-015-0315-2 · Cited by 824
Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C., Buono, D., Eckholdt, H., Howard, A. A., & Schoenbaum, E. E. (2001) · Clinical Infectious Diseases · doi:10.1086/323201 · Cited by 637
Adherence to combination antiretroviral therapies in HIV patients of low health literacy
Kalichman, S. C., Ramachandran, B., & Catz, S. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.00334.x · Cited by 631
Carr, A., Miller, J., Law, M., & Cooper, D. A. (2000) · AIDS · doi:10.1097/00002030-200002180-00001 · Cited by 630
Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., & Stefaniak, M. (2004) · AIDS · doi:10.1097/00002030-200418001-00004 · Cited by 551
Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002) · Journal of General Internal Medicine · doi:10.1007/s11606-002-0044-3 · Cited by 501
Bhaskaran, K. (2008) · JAMA · doi:10.1001/jama.300.1.51 · Cited by 496
Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200004150-00005 · Cited by 460
Galvan, F. H., Bing, E. G., Fleishman, J. A., London, A. S., Caetano, R., Burnam, M. A., Longshore, D., Morton, S. C., Orlando, M., & Shapiro, M. (2002) · Journal of Studies on Alcohol · doi:10.15288/jsa.2002.63.179 · Cited by 438
Kim, S.-H., Gerver, S. M., Fidler, S., & Ward, H. (2014) · AIDS · doi:10.1097/qad.0000000000000316 · Cited by 431
Elovainio, M., Hakulinen, C., Pulkki-Råback, L., Virtanen, M., Josefsson, K., Jokela, M., Vahtera, J., & Kivimäki, M. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30075-0 · Cited by 411
Langebeek, N., Gisolf, E. H., REISS, P. C., Vervoort, S. C. J. M., Hafsteinsdøttir, T. B., Richter, C., Sprangers, M. A. G., & Nieuwkerk, P. T. (2014) · BMC Medicine · doi:10.1186/preaccept-1453408941291432 · Cited by 405
Langebeek, N., Gisolf, E. H., Reiss, P., Vervoort, S. C., Hafsteinsdóttir, T. B., Richter, C., Sprangers, M. A., & Nieuwkerk, P. T. (2014) · BMC Medicine · doi:10.1186/s12916-014-0142-1 · Cited by 394
Chesney, M. (2003) · AIDS Patient Care and STDs · doi:10.1089/108729103321619773 · Cited by 373
Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis
Conn, V. S., & Ruppar, T. M. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.03.008 · Cited by 367 · cited 1×
“On a similar note, a recent meta-analysis on different methods and their effectiveness disclosed the superiority of electronic monitoring compared with other methods (Conn and Ruppar, 2017).”
ResultA Review of the Toxicity of HIV Medications
Margolis, A. M., Heverling, H., Pham, P. A., & Stolbach, A. (2014) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0325-8 · Cited by 348
The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future
Kay, E. S., Batey, D. S., & Mugavero, M. J. (2016) · AIDS Research and Therapy · doi:10.1186/s12981-016-0120-0 · Cited by 333
Adherence to Highly Active Antiretroviral Therapy (HAART): A Meta-Analysis
Ortego, C., Huedo-Medina, T. B., Llorca, J., Sevilla, L., Santos, P., Rodríguez, E., Warren, M. R., & Vejo, J. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-9942-x · Cited by 310
Addressing the Challenges of Adherence
Bartlett, J. A. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200202011-00002 · Cited by 307
Drug Use and Medication Adherence among HIV-1 Infected Individuals
Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., Myers, H. F., & Longshore, D. (2007) · AIDS and Behavior · doi:10.1007/s10461-006-9152-0 · Cited by 305
Wing, E. J. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.10.004 · Cited by 287
Yun, L. W. H., Maravi, M., Kobayashi, J. S., Barton, P. L., & Davidson, A. J. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000147524.19122.fd · Cited by 283
Problem Drinking and Medication Adherence Among Persons with HIV Infection
Cook, R. L., Sereika, S. M., Hunt, S. C., Woodward, W. C., Erlen, J. A., & Conigliaro, J. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.00122.x · Cited by 280
Nieuwkerk, P. T. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.16.1962 · Cited by 250
Alcohol Consumption and Antiretroviral Adherence Among HIV‐Infected Persons With Alcohol Problems
Samet, J. H., Horton, N. J., Meli, S., Freedberg, K. A., & Palepu, A. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000122103.74491.78 · Cited by 238
Fernandes, R. M., Cary, M., Duarte, G., Jesus, G., Alarcão, J., Torre, C., Costa, S., Costa, J., & Carneiro, A. V. (2017) · BMC Public Health · doi:10.1186/s12889-017-4210-2 · Cited by 236
Interventions to improve adherence to antiretroviral therapy: a rapid systematic review
Chaiyachati, K. H., Ogbuoji, O., Price, M., Suthar, A. B., Negussie, E. K., & Bärnighausen, T. (2014) · AIDS · doi:10.1097/qad.0000000000000252 · Cited by 235
Real-Time Adherence Monitoring for HIV Antiretroviral Therapy
Haberer, J. E., Kahane, J., Kigozi, I., Emenyonu, N., Hunt, P., Martin, J., & Bangsberg, D. R. (2010) · AIDS and Behavior · doi:10.1007/s10461-010-9799-4 · Cited by 231
Wood, E., Montaner, J. S. G., Yip, B., TYNDALL, M. W., Schechter, M. T., O’Shaughnessy, M. V., & Hogg, R. S. (2003) · Europe PMC (PubMed Central) · Cited by 223
Substance use: impact on adherence and HIV medical treatment
Gonzalez, A., Barinas, J., & O’Cleirigh, C. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0093-5 · Cited by 195
Shi, L., Liu, J., Koleva, Y., Fonseca, V., Kalsekar, A., & Pawaskar, M. (2010) · PharmacoEconomics · doi:10.2165/11537400-000000000-00000 · Cited by 189
Haberer, J. E., Sabin, L., Amico, K. R., Orrell, C., Galárraga, O., Tsai, A. C., Vreeman, R. C., Wilson, I., Sam‐Agudu, N. A., Blaschke, T. F., et al. (2017) · Journal of the International AIDS Society · doi:10.7448/ias.20.1.21371 · Cited by 181
Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200004150-00005 · Cited by 170
Crack, crack house sex, and HIV risk
Inciardi, J. A. (1995) · Archives of Sexual Behavior · doi:10.1007/bf01541599 · Cited by 165
Altice, F. L., Maru, D., Bruce, R. D., Springer, S. A., & Friedland, G. (2007) · Clinical Infectious Diseases · doi:10.1086/521166 · Cited by 158
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review
Bierman, W. F. W., van Agtmael, M. A., Nijhuis, M., Danner, S. A., & Boucher, C. A. (2009) · AIDS · doi:10.1097/qad.0b013e32831c54e5 · Cited by 152
The Dynamic Relationship Between Social Support and HIV-Related Stigma in Rural Uganda
Takada, S., Weiser, S. D., Kumbakumba, E., Muzoora, C. K., Martin, J. N., Hunt, P. W., Haberer, J. E., Kawuma, A., Bangsberg, D. R., & Tsai, A. C. (2014) · Annals of Behavioral Medicine · doi:10.1007/s12160-013-9576-5 · Cited by 146
Mountain, E., Mishra, S., Vickerman, P. T., Pickles, M., Gilks, C. F., & Boily, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105645 · Cited by 143
Viswanathan, S., Detels, R., Mehta, S. H., Macatangay, B. J. C., Kirk, G. D., & Jacobson, L. P. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0927-4 · Cited by 139
Measuring medication adherence: Are missed doses reported more accurately than perfect adherence?
Wagner, G. J., & Rabkin, J. G. (2000) · AIDS Care · doi:10.1080/09540120050123800 · Cited by 128
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)
Spire, B., Lucas, G. M., & Carrieri, P. (2007) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.12.014 · Cited by 125
Cluver, L. D., Orkin, F. M., Boyes, M. E., & Sherr, L. (2014) · AIDS · doi:10.1097/qad.0000000000000340 · Cited by 120
Clay, P. G., Nag, S., Graham, C. M., & Narayanan, S. (2015) · Medicine · doi:10.1097/md.0000000000001677 · Cited by 109
Ford, N. P., Nachega, J. B., Engel, M. E., & Mills, E. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61671-8 · Cited by 105
Millar, B. M., Starks, T. J., Gurung, S., & Parsons, J. T. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1613-5 · Cited by 94
Kirsten, I., Sewangi, J., Kunz, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021020 · Cited by 84
Cantudo-Cuenca, M. R., Jiménez-Galán, R., Almeida, C., & Morillo‐Verdugo, R. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.8.844 · Cited by 83
Macalino, G. E., Hogan, J. W., Mitty, J. A., Bazerman, L. B., DeLong, A. K., Loewenthal, H. G., Caliendo, A. M., & Flanigan, T. (2007) · AIDS · doi:10.1097/qad.0b013e32811ebf68 · Cited by 82
Cluver, L. D., Orkin, F. M., Meinck, F., Boyes, M. E., & Sherr, L. (2016) · Journal of the International AIDS Society · doi:10.7448/ias.19.1.20646 · Cited by 78
Use of pharmacy refill data as a measure of antiretroviral adherence
Grossberg, R. M., & Gross, R. (2007) · Current HIV/AIDS Reports · doi:10.1007/s11904-007-0027-4 · Cited by 76
Graham, S. M., Mugo, P. M., Gichuru, E., Thiong’o, A. N., Macharia, M., Okuku, H. S., van der Elst, E., Price, M. A., Muraguri, N., & Sanders, E. J. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0445-9 · Cited by 76
Adherence to antiretroviral therapy
FRCN, R. J. P. C. (2003) · CRC Press eBooks · doi:10.1201/b13504-26 · Cited by 75
Orrell, C., Cohen, K., Leisegang, R., Bangsberg, D., Wood, R., & Maartens, G. (2017) · AIDS Research and Therapy · doi:10.1186/s12981-017-0138-y · Cited by 69
Kelly, C., van Oosterhout, J. J., Ngwalo, C., Stewart, R. C., Benjamin, L. A., Robertson, K. R., Khoo, S., Allain, T. J., & Solomon, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098962 · Cited by 65
Sex differences in adherence to highly active antiretroviral therapy: A meta-analysis
Ortego, C., Huedo-Medina, T. B., dos Santos, P. H. S., Rodríguez‐Rodríguez, E., Sevilla, L., Warren, M., & Llorca, J. (2012) · AIDS Care · doi:10.1080/09540121.2012.672722 · Cited by 60
Barai, N., Monroe, A., Lesko, C., Lau, B., Hutton, H., Yang, C., Alvanzo, A., McCaul, M. E., & Chander, G. (2017) · AIDS and Behavior · doi:10.1007/s10461-016-1580-x · Cited by 53
Sidat, M., Fairley, C. K., & Grierson, J. (2007) · AIDS Patient Care and STDs · doi:10.1089/apc.2006.0201 · Cited by 43
Johnson, C. J., Heckman, T. G., Hansen, N. B., Kochman, A., & Sikkema, K. J. (2009) · AIDS Care · doi:10.1080/09540120802385611 · Cited by 42
Liu, A., Hessol, N. A., Vittinghoff, E., Amico, K. R., Kroboth, E., Fuchs, J. D., Irvin, R., Sineath, R. C., Sanchez, T., Sullivan, P. S., et al. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2014.0195 · Cited by 39
Expanding directly observed therapy: tuberculosis to human immunodeficiency virus
Bangsberg, D. R., Mundy, L. M., & Tulsky, J. P. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00729-x · Cited by 38
Kumar, V., & Encinosa, W. E. (2009) · Psychiatric Quarterly · doi:10.1007/s11126-009-9100-z · Cited by 36
Aharonovich, E., Greenstein, E., O’Leary, A., Johnston, B. E., Seol, S. G., & Hasin, D. S. (2012) · AIDS Care · doi:10.1080/09540121.2012.663882 · Cited by 36
Uthman, O. A., Oladimeji, O., & Nduka, C. U. (2016) · AIDS Care · doi:10.1080/09540121.2016.1223799 · Cited by 35
Wanchu, A., Kaur, R., BAMBERY, P., & Singh, S. R. (2006) · AIDS and Behavior · doi:10.1007/s10461-006-9101-y · Cited by 34
Prevalence of concomitant medications in older HIV+ patients and comparison with general population
Gimeno-Gracia, M., Crusells-Canales, M. J., Armesto-Gómez, F. J., & Rabanaque, M. J. (2015) · HIV Clinical Trials · doi:10.1179/1528433614z.0000000012 · Cited by 34
Social support and delays seeking care after HIV diagnosis, North Carolina, 2000–2006
McCoy, S. I., Strauss, R. P., MacDonald, P. D. M., Leone, P. A., Eron, J. J., & Miller, W. C. (2009) · AIDS Care · doi:10.1080/09540120902730021 · Cited by 27
Harm reduction intensity—Its role in HAART adherence amongst drug users in Amsterdam
Lambers, F. A. E., Stolte, I. G., van den Berg, C. H. S. B., Coutinho, R. A., & Prins, M. (2011) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2011.02.004 · Cited by 23
Hayashi, K., Wood, E., Kerr, T. H., Dong, H., Nguyen, P., Puskas, C. M., Guillemi, S. A., Montaner, J. S. G., & Milloy, M. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1749-y · Cited by 19
Cited by
mHealth Interventions to Promote Anti-Retroviral Adherence in HIV: Narrative Review
Lee, S. B., & Valerius, J. (2020) · JMIR mHealth and uHealth · doi:10.2196/14739 · Cited by 34
“One meta-analysis reported adherence at 62%, and studies on subgroups, such as illicit drug users, are as low as 27% [17,18].”
Background
Metadata
- Authors
- Iacob, S. A., Iacob, D. G., & Jugulete, G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-11-23
- Volume
- 8
- Pages
- 831-831
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2769261452
- Cited by
- 265
- References
- 75
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.